![](/img/cover-not-exists.png)
PNS229 COMPARATIVE ANALYSIS OF TRANSPARENCY COMMITTEE OPINION CONCERNING THE ADDED MEDICAL BENEFIT OBTAINED BY DRUGS AVAILABLE THROUGH EARLY ACCESS PROGRAM VS THE OTHERS
Benazet, F., Le Tohic, D., Gurnot, S., Andriany, T., Berard, I.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2129
Date:
November, 2019
File:
PDF, 383 KB
2019